Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00681512 · ClinicalTrials.gov registry record · NA

The Effect of Berries on Lung Cancer Tumors

A NA study, sponsored by University of Louisville.

Terminated
Registry status
NA
Development phase
6
Enrollment target

NCT00681512: Clinical Trial NA study, sponsored by University of Louisville.

NCT00681512 is a NA study that was terminated before completion, run by University of Louisville. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00681512, a NA study, was terminated before completion, sponsored by University of Louisville.

TERMINATED
Registry status
NA
Development phase
6 participants
Enrollment target

Study Summary

The purpose of this study is to determine how berries affect cancer tumors in patients with non-small cell lung cancer.

Primary Outcome

In addition to determining the berry phytochemical profile in plasma and urine, this study will attempt to establish the effect of berries on modulating immunological profiles such as the complete blood count, and T, B and natural killer (NK) cell populations and circulating biomarkers (serum proteins and microRNAs). This pilot study will establish the safety and feasibility of conducting a larger clinical trial with berry intervention.

Interventions

  • DIETARY_SUPPLEMENT berry powder

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2008-04
Est. Completion 2013-12
Phase NA
University of Louisville

217 total trials

Why NCT00681512 stopped before completion

NCT00681512 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which berry powder is the first listed.

NCT00681512 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00681512 about?

NCT00681512 is a clinical study titled "The Effect of Berries on Lung Cancer Tumors". The purpose of this study is to determine how berries affect cancer tumors in patients with non-small cell lung cancer.

What is the current status of trial NCT00681512?

This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2008-04. Estimated completion is 2013-12.

What interventions are being tested in trial NCT00681512?

The interventions under investigation include: berry powder (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00681512?

This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00681512's enrollment target sits among peer trials

6 1983rd of 2000 higher than 13 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00681512, the US trial registry maintained by the National Library of Medicine. NCT00681512 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.